Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Enrico Maraolo

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Antibiotics (Basel, Switzerland)|December 23, 2023
Editorial for the Special Issue: "The Issue of Multidrug-Resistant Pathogens in Nosocomial Infections"Alberto Enrico Maraolo
Antibiotics (Basel, Switzerland)|April 23, 2022
Editorial for the Special Issue: "Current and Novel Antimicrobial Strategies for Bacterial and Fungal Infections by Resistant Organisms"Alberto Enrico Maraolo
Expert Opinion on Pharmacotherapy|April 2, 2021
Choosing the appropriate pharmacotherapy for hepatitis B during pregnancy: what are the considerations?Alberto Enrico Maraolo
Critical Care (London, England)|November 30, 2016
Reassessing the death risk related to probiotics in critically ill patientsAlberto Enrico Maraolo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2025
It is time to go beyond the association between colistin and meropenem for invasive carbapenem-resistant Acinetobacter baumannii infectionsAlberto Enrico Maraolo, Giancarlo Ceccarelli
Immunity, Inflammation and Disease|November 27, 2020
Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trialsAlberto Enrico Maraolo, Adriano Grossi
Journal of Infection in Developing Countries|January 22, 2024
Predisposing factor, impactful adjunctive treatment or unfavorable prognostic marker: a meta-analysis on the elusive role of dexamethasone for Listeria monocytogenes meningitisAlberto Enrico Maraolo, Maria Mazzitelli
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2026
Which trials do we need? The never-ending quest for an oral switch regimen in culture-negative prosthetic valve infective endocarditisGiuseppe Pipitone, Guido Granata, Alberto Enrico Maraolo
Annals of Medicine|May 11, 2026
Ceftriaxone for methicillin-susceptible <i>Staphylococcus aureus</i> bloodstream infections is associated with increased short-term mortality: a systematic review and meta-analysisAlberto Enrico Maraolo, Mariano Nobile, Ivan Gentile
Expert Review of Anti-Infective Therapy|September 7, 2016
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?Ivan Gentile, Alberto Enrico Maraolo, Guglielmo Borgia
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Antibiotics (Basel, Switzerland)|December 23, 2023
Editorial for the Special Issue: "The Issue of Multidrug-Resistant Pathogens in Nosocomial Infections"Alberto Enrico Maraolo
Antibiotics (Basel, Switzerland)|April 23, 2022
Editorial for the Special Issue: "Current and Novel Antimicrobial Strategies for Bacterial and Fungal Infections by Resistant Organisms"Alberto Enrico Maraolo
Expert Opinion on Pharmacotherapy|April 2, 2021
Choosing the appropriate pharmacotherapy for hepatitis B during pregnancy: what are the considerations?Alberto Enrico Maraolo
Critical Care (London, England)|November 30, 2016
Reassessing the death risk related to probiotics in critically ill patientsAlberto Enrico Maraolo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2025
It is time to go beyond the association between colistin and meropenem for invasive carbapenem-resistant Acinetobacter baumannii infectionsAlberto Enrico Maraolo, Giancarlo Ceccarelli
Immunity, Inflammation and Disease|November 27, 2020
Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trialsAlberto Enrico Maraolo, Adriano Grossi
Journal of Infection in Developing Countries|January 22, 2024
Predisposing factor, impactful adjunctive treatment or unfavorable prognostic marker: a meta-analysis on the elusive role of dexamethasone for Listeria monocytogenes meningitisAlberto Enrico Maraolo, Maria Mazzitelli
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2026
Which trials do we need? The never-ending quest for an oral switch regimen in culture-negative prosthetic valve infective endocarditisGiuseppe Pipitone, Guido Granata, Alberto Enrico Maraolo
Annals of Medicine|May 11, 2026
Ceftriaxone for methicillin-susceptible <i>Staphylococcus aureus</i> bloodstream infections is associated with increased short-term mortality: a systematic review and meta-analysisAlberto Enrico Maraolo, Mariano Nobile, Ivan Gentile
Expert Review of Anti-Infective Therapy|September 7, 2016
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?Ivan Gentile, Alberto Enrico Maraolo, Guglielmo Borgia
Pageof 13